ABSTRACT
El linfoma anaplásico de células grandes asociado a implantes mamarios (BIA-ALCL según sus siglas en inglés) es un tipo raro de linfoma no Hodgkin que se ha descrito en el contexto de la cirugía reconstructiva y estética de mama mediante implantes. Estos artículos presentan un consenso de la Sociedad Española de Senología y Patología Mamaria (SESPM) con la idea de unificar, en esta primera parte, los criterios de diagnóstico de esta enfermedad describiendo asimismo la epidemiología y la etiopatogenia
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare type of non-Hodgkin lymphoma that has been described in the context of reconstructive and aesthetic breast implant surgery. These articles present a consensus of the Spanish Society of Senology and Breast Disease (SESPM). In this first part, the aim is to unify the diagnostic criteria of this disease and describe its epidemiology and etiopathogenesis
Subject(s)
Humans , Female , Lymphoma, Large-Cell, Anaplastic/diagnosis , Breast Implants/adverse effects , Breast Neoplasms/pathology , Mammography/statistics & numerical data , Prostheses and Implants/adverse effects , Consensus , Breast Neoplasms/epidemiology , Lymphoma, Large-Cell, Anaplastic/epidemiology , Neoplasms, Second Primary/pathology , Lymphoma, Large-Cell, Anaplastic/pathology , Biopsy/methods , Practice Patterns, Physicians'ABSTRACT
El linfoma anaplásico de células grandes asociado a implantes mamarios (BIA-ALCL según sus siglas en inglés) es un tipo raro de linfoma no Hodgkin que se ha descrito en el contexto de la cirugía reconstructiva y estética de mama mediante implantes. Este segundo artículo presenta la parte del consenso de la Sociedad Española de Senología y Patología Mamaria (SESPM) sobre el tratamiento quirúrgico, médico, radioterápico, pronóstico y seguimiento
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare type of non-Hodgkin lymphoma that has been described in the context of breast implant reconstructive and cosmetic surgery. This second article presents the consensus of the Spanish Society of Senology and Breast Disease (SESPM) on the medical and surgical treatment of this disease, radiotherapy, prognosis and follow-up
Subject(s)
Humans , Female , Lymphoma, Large-Cell, Anaplastic/therapy , Breast Implants/adverse effects , Breast Neoplasms/therapy , Antineoplastic Agents/therapeutic use , Radiotherapy/methods , Prostheses and Implants/adverse effects , Consensus , Breast Neoplasms/pathology , Lymphoma, Large-Cell, Anaplastic/pathology , Neoplasms, Second Primary/pathology , Practice Patterns, Physicians' , Neoplasm Staging/methods , PrognosisABSTRACT
No disponible
Angiosarcoma of the breast is a rare malignant tumour.It can be primary or secondary in womenwho have been treated of a ductal carcinoma of thebreast. There are some differences between boththem. We present two clinical cases secondary to radiotherapyand a review of the literature, discussingabout aetiology, incidence, diagnostic, treatmentand prognostic of this tumours
